Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Companyâs Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.
äŒæ¥ã³ãŒãMOBI
äŒç€ŸåMobia Medical Inc
äžå Žæ¥May 08, 2026
æé«çµå¶è²¬ä»»è
ãCEOãFoust (Richard John)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«- -
æ¬ç€Ÿæåšå°2802 Flintrock Trace, Suite 226
éœåž
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·78738
é»è©±çªå·
ãŠã§ããµã€ã
äŒæ¥ã³ãŒãMOBI
äžå Žæ¥May 08, 2026
æé«çµå¶è²¬ä»»è
ãCEOãFoust (Richard John)